Evidence map›Paper›PMID 41288653›Full record

ArticleIntensive care medicine2026

Trends in renal replacement therapy use in intensive care unit: insights from a French multicenter cohort.

Julien Schmidt, Lamiae Grimaldi, Patricia Martel, Céline Piedvache, Bertrand Guidet, Khalil Chaïbi, Didier Dreyfuss, Stéphane Gaudry

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julien SchmidtService de Réanimation Médico-Chirurgicale, AP-HP, Hôpital Avicenne, Université Sorbonne Paris Nord, Bobigny, France.
Lamiae GrimaldiClinical Research Unit, APHP, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
Patricia MartelClinical Research Unit, APHP, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
Céline PiedvacheClinical Research Unit, APHP, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
Bertrand GuidetMédecine Intensive Réanimation, APHP, Hôpital Saint Antoine, Paris, France.
Khalil ChaïbiService de Réanimation Médico-Chirurgicale, AP-HP, Hôpital Avicenne, Université Sorbonne Paris Nord, Bobigny, France.
Didier Dreyfuss *Common and Rare Kidney Diseases, Sorbonne Université, INSERM, UMR-S 1155, 75020, Paris, France.
Stéphane Gaudry *Service de Réanimation Médico-Chirurgicale, AP-HP, Hôpital Avicenne, Université Sorbonne Paris Nord, Bobigny, France. stephanegaudry@gmail.com.ORCID 0000-0002-1105-6785

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRenal replacement therapy (RRT) during acute kidney injury (AKI) in critically ill patients used to be started early for long. Recent trials supporting a conservative approach with delayed RRT initiation may have influenced clinical practice. We aim to assess temporal trends in the use of RRT among intensive care unit (ICU) patients with AKI over a 12-year period. MATERIALS AND

methodsWe conducted a retrospective cohort study using data from the CUB-Réa database, including ICU patients with AKI who required invasive mechanical ventilation and/or catecholamine infusion between 2008 and 2019. Patients were grouped into three periods based on the calendar year of ICU stay: 2008-2011, 2012-2015, and 2016-2019. The primary outcome was the temporal trend in RRT utilization. Secondary outcomes included annual crude RRT rates per 1000 ICU stays and trends in RRT modality. Multivariable logistic regression was used to adjust for confounders. We used a monthly interrupted time series (ITS) over 2008-2019 with a prespecified breakpoint at July 2016 (AKIKI trial publication).

resultsAmong 45,242 eligible ICU stays, 16,999 (37.6%) required RRT. The use of RRT decreased over the study period, from 39.7% in 2008-2011 to 37.4% in 2012-2015, and to 35.9% in 2016-2019 (p < 0.0001). Adjusted analyses confirmed this trend, with an odds ratio (OR) of 0.91 (95% CI 0.87-0.96) for 2012-2015 and 0.80 (95% CI 0.76-0.84) for 2016-2019, compared to the baseline period. In the adjusted ITS analysis, only the post-intervention monthly trend reached statistical significance (RR per year = 0.97; 95% CI 0.94-0.99). The annual crude rate of RRT use declined from 441 per 1000 ICU stays at baseline to 339 in 2019 (relative reduction: 20.8%). Use of intermittent RRT declined, while continuous modestly increased.

conclusionsAmong critically ill patients with AKI, RRT use decreased in the past decade. This suggests a progressive shift toward more conservative RRT initiation strategies.

Indexed as

Acute Kidney InjuryIntensive Care UnitsRenal Replacement TherapyAgedCohort StudiesCritical IllnessFemaleFranceHumansMaleMiddle AgedRetrospective StudiesAcute kidney injuryEpidemiologyRenal replacement therapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.